AmLactin®, the #1 moisturizer brand recommended by dermatologists for rough, dry skin, is donning a fresh, new look while bringing dry skin sufferers the same effective, hard-working formulas. The makeover comes with a new family name: AmLactin® Alpha-Hydroxy Skin Care. The contemporary design graces white, pearlescent bottles and tubes complemented by a series of vibrant colors and a signature droplet to convey the line’s intensity and success at helping skin retain its moisture.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55256-amlactin-alpha-hydroxy-skin-care-moisturizer
Could migraine patients be doing more to get the most out of their medical visits? According to a new national survey released by the National Headache Foundation (NHF) and GlaxoSmithKline, the answer is yes. For the nearly 30 million migraine sufferers in the U.S., including six million treating with prescription medication, these survey results may have important implications.
The survey, conducted online in November 2010 by Harris Interactive, included 1,218 diagnosed migraine patients taking prescription medications for their migraine attacks as well as 533 physicians who treat between five and 10 migraine patients per week. The findings revealed disparities between what patients and physicians each reported typically discussing during office visits.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/glaxosmithkline/48596/
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Life is unpredictable and can be even more so when you have allergies. During this fall allergy season, your runny nose, sneezing or itchy, watery eyes just might earn you top honors in Allegra's new Allergy Adventures contest on Facebook. Allergy sufferers are invited to upload a short video showing their daily challenges with allergies for a chance to win $5,000 toward a fun-filled adventure where they can enjoy life – without worrying about allergies.
Over 40 million adults suffer from indoor and outdoor allergies in the United States. During the fall, many people suffer from allergy triggers such as ragweed and dust mites. The contest is meant to help people say farewell to disruptive allergy symptoms now that fast (starts working at hour one), long-lasting, non-drowsy relief is available over-the-counter from Allegra.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/allegra/50885/
Many cold sore sufferers try to tough out cold sores or try home remedies that can possibly make their cold sore even worse. There\'s a lot to be learned about the pesky cold sore that you may not know. For example, did you know that as temperatures drop and cold-weather-related illnesses rise, the chance of a cold sore being triggered increases? Cold temperatures and illness are just two triggers that can cause cold sore outbreaks. Other triggers include stress, sun exposure, injury to the mouth, and lack of sleep. Stress, which tends to rear its head during the winter months as many people prepare for the holidays, coupled with cold weather can create the perfect storm for a cold sore outbreak as we enter cold and flu season. Find out how FDA-approved Abreva allows you to win a speedy victory against cold sore attacks.
http://www.debbiewilliamsassociates.co.uk/free_download.htm#free_download Cancer help with hypnosis. This recording can help lift stress and teach you how to relax. also there are many stories of spontaneous remissions on my website and video testimonials of hopw it has helped them and it is completely free
The Asthma and Allergy Foundation of America (AAFA) and Teva Respiratory released results today from a new survey which showed that more than half (59 percent) of nasal allergy sufferers polled reported sleep issues as a result of their allergy symptoms, yet only 35 percent proactively treat their nasal allergy symptoms. Furthermore, nearly half of those surveyed (48 percent) said their nasal allergy symptoms, such as nasal congestion and sneezing, also interrupted their partner’s sleep.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60975-teva-respiratory-aafa-ditch-the-drip-misty-may-treanor-nasal-allergies
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
Eight out of 10 people will be affected by back pain at some point during their lives, making it the No. 1 cause of disability worldwide and resulting in as much as $200 billion in lost wages and productivity. Many sufferers struggle for years to find relief, but treatment options often only provide short-term relief or, in the case of pain medication, carry serious side effects, including drowsiness, liver damage and potential for addiction. Now, thanks to Hocoma, a leader in the development of robotic and sensor-based medical devices for functional movement therapy, consumers have a new way to improve and sustain low back health in the comfort of their own home.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7370551-hocoma-innovative-medical-device-therapeutic-gaming-technology-valedo-low-back-health/
Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64826-issels-recurrent-lung-cancer-responds-to-integrative-immunotherapy
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
Entering its 10th year of providing gout education, the Gout & Uric Acid Education Society (GUAES) is amplifying its efforts on May 22 – National Gout Awareness Day – and encouraging gout sufferers to seek immediate and ongoing treatment. Information and resources are available to both the general public and medical professionals through the organization’s new website, found at GoutEducation.org.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7134051-gout-and-uric-acid-education-society-national-gout-awareness-day
